期刊文献+

取代苯类化合物的二维全息定量结构—活性相关研究 被引量:1

Study on 2-Dimension Hologram Quantitative Structure-Activity Relationship for Substituted Benzenes
在线阅读 下载PDF
导出
摘要 为了预测非反应性麻醉型化合物对发光菌的发光半抑制浓度,评价该类化合物的毒性效应,采用独特的二维HQSAR分析方法,根据分子碎片的类型,将分子结构转变成具有特征的分子指纹,并用数字进行标记。这些标记出的数字作为QSAR的描述符,经过偏最小二乘法计算,建立起化合物结构与生物毒性之间的相关关系,由此所获得的HQSAR预测值与实测值之间也存在较好的相关性,即-1g_(pre)EC_(50)=0.311+0.929(-1g_(exp)EC_(50))(n=13,r=0.964)。这一模型的预测效果明显优于传统的二维QSAR模型,其结果可以为定量评估同类化合物的生物毒性提供可靠依据。 In this study, 2-dimension HQSAR analysis technique has been performed on unreactive narcotic compounds, examining the concentration values causing a 50% inhibition of bioluminescence of Photobacterium phosphoreum after 15 minutes exposure. HQSAR converts the molecules of a data set into counts of their constituent fragments. These fragment counts are then related to biological data using Partial Least Squares (PLS) analysis. A good relationship between predicted data by HQSAR and observed data were obtained: -lgpreEC50 = 0.311+0.929(-lgexpEC50) (n=13, y =0.964). Trials on a number of data sets have shown that HASAR could give more accurate results comparable with sophisticated 2D QSAR techniques for evaluation of toxicity effect.
出处 《上海环境科学》 CAS CSSCI CSCD 北大核心 2003年第12期958-961,共4页 Shanghai Environmental Sciences
基金 国家自然科学基金 No.29977008 20177008
关键词 全息定量结构-活性相关 发光菌 生物毒性 预测模型 取代苯类化合物 Hologram quantitative structure-activity relationship Photobactierium phosphoreum Toxicity effect Prediction model
  • 相关文献

参考文献8

二级参考文献36

共引文献131

同被引文献13

  • 1王海燕,王晓栋,赵劲松,孙成,王连生.应用分子全息对多氯代二苯并呋喃的QSRR研究[J].科学通报,2005,50(5):422-425. 被引量:6
  • 2李华,张华北.3-吡啶基醚类化合物的分子全息QSAR研究[J].化学学报,2005,63(11):1018-1022. 被引量:6
  • 3汤慧芳,陈季强,王鹏.磷酸二酯酶4作为抗炎药物靶点的研究现状及未来发展方向[J].中国药科大学学报,2006,37(1):9-13. 被引量:9
  • 4Pierre R, Dominique S. Cyclic nucleotide phosphodiesterase type 4 inhibitors: evaluation of pyrazolo [ 1,5-a]-1, 3, 5- triazine ring system as an adenine bioisostere [ J ]. European Journal of Medicirud Chemistry ,2007 ,5 :1-14.
  • 5Rongze K, Ho-Jane S. Discovery of a highly potent series of oxazole-based Phosphodiesterase 4 inhibitors [ J ]. Bioorganic & Medicinal Chemistry Letters, 2007, 17 : 5150-5154.
  • 6Nam-Sook K, Seok-Joo H. Comparative molecular field analysis ( CoMFA ) for phosphodiesterase ( PDE ) IV inhibitors [ J ]. Journal of Molecular Structure, 2007,820 : 58-64.
  • 7Jennifer A, Jerry A. Murry. Practical application of new catalytic methods:a concise synthesis of a potent PDE IV inhibitor[ J ]. Tetrahedron,2005,61:6330-6336.
  • 8Allen J, Elizabeth L. SAR of a Series of 5,6-Dihydro- (9H) -pyrazolo [ 3,4-c ] -1,2,4.-triazolo [ 4,3-a ] pyridines as Poent Inhibitors of Human Eosinophil Phosphodiesterase [ J ]. J. Med. Chem. 2007,50 : 344-349.
  • 9Sung-Sau S, Martin K. A comparative study of ligandreceptor complex binding affinity prediction methods based on glycogen phosphorylase inhibitors [ J ]. Journal of Computer-Aided Molecular Design, 1999,13:243-258.
  • 10Carlos R, Terrence M. CoMFA and HQSAR of Acylhydrazide Cruzain Inhibitors [ J ]. Bioorganic and Medicinal Chemistry Letters ,2002,12 : 1537-1541.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部